Per financial data disclosed in the securities registration statement, Bowon Chemical recorded revenues of KRW 26.2B in 2022 (operating loss of KRW 0.2B), KRW 32.6B in 2023 (operating profit of KRW 1.0B), and KRW 39.4B in 2024 (operating profit of KRW 4.8B) — a three-year revenue CAGR of 22.6%.
Gross margin rebounded sharply from 15.5% in 2022 to 34.6% in 2024, as LX Hausys's 2023 exit from the automotive interior market and the resulting market share gains fed directly into operating leverage.
On a consolidated basis, 2024 revenue of KRW 39.7B and operating profit of KRW 4.7B have also been reported, marginally differing from the registration statement figures but directionally consistent.
At its January 2026 investor conference, management provided FY2025 guidance of KRW 55.6B in revenue and KRW 6.6B in operating profit; these remain forward-looking estimates, and actual results require confirmation through official regulatory filings.
On the share price trajectory, the stock gained 13.66% on its KOSDAQ debut (April 3, 2026) and hit the daily upper circuit limit of 29.99% at KRW 11,790 on April 6, reflecting strong initial post-IPO momentum.
The stock subsequently reversed sharply, falling to KRW 3,255 by June 7, 2026 — approximately 72% below the early post-IPO high.
Bowon Chemical was designated as a short-selling overheating stock on May 15, 2026, with the designation extended, underscoring persistent supply-demand imbalance; the effective deployment of IPO proceeds (KRW 5.1B facility, KRW 2.0B R&D, KRW 1.0B debt, KRW 1.3B working capital) will be a key catalyst determinant going forward.